Aayush Wellness launches Lung Care Tablets in ₹18,913 crore market
- Aayush Wellness launched Lung Care Tablets on August 29, 2026
- Product targets smokers and individuals with respiratory issues
- Enters a ₹18,913 crore respiratory healthcare market
- Segment sales grew ~10% YoY to ₹18,912.64 crore in 2025

*this image is generated using AI for illustrative purposes only.
Mumbai, August 29, 2026 — Aayush Wellness launched Lung Care Tablets on August 29, 2026, entering the ₹18,913 crore respiratory healthcare market. The product targets smokers and individuals with respiratory issues.
The company disclosed the launch under Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. Managing Director Naveenakumar Kunjaru stated the move aligns with the firm’s prevention-led vision, building on the success of Aayush Herbal Masala.
Market Context
India’s respiratory healthcare segment recorded sales of ₹18,912.64 crore in 2025, up from ₹17,199.40 crore in 2024. This represents approximately 10% year-on-year growth. The company noted that India accounts for 30.28% of global deaths from respiratory diseases.
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Respiratory Segment Sales | ₹18,912.64 crore | ₹17,199.40 crore | ~10% |
Product Formulation
Lung Care Tablets combine herbal and nutritional ingredients, including N-Acetyl Cysteine (NAC), Vasaka Extract, Licorice, Quercetin, Vitamin C, Vitamin D2, and Zinc. The formulation aims to support:
- Respiratory wellness and lung function
- Healthy airway function
- Antioxidant and immune support
- Healthy inflammatory response
- Overall lung-health maintenance
What the Numbers Show
The 10% growth in the respiratory segment sales from ₹17,199.40 crore in 2024 to ₹18,912.64 crore in 2025 indicates consistent expansion in this therapeutic category. This growth trajectory supports the company’s strategic entry into a market where India holds a significant share of global disease burden.
Strategic Outlook
Aayush Wellness positions the new tablets as a daily wellness solution to complement its existing preventive-health products. The company aims to increase product depth and create cross-selling opportunities across its customer base by addressing rising health concerns with targeted solutions.
Historical Stock Returns for Aayush Wellness
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.65% | -3.82% | +9.83% | -22.52% | -56.71% | +1,157.50% |
How will Aayush Wellness differentiate its Lung Care Tablets from established pharmaceutical competitors in the respiratory segment?
What is the projected timeline for Aayush Wellness to achieve significant market share penetration within the ₹18,913 crore respiratory healthcare market?
Will the company face regulatory challenges regarding health claims for herbal formulations containing N-Acetyl Cysteine and other active ingredients?


































